| 查看: 751 | 回复: 0 | |||
[交流]
纽约Weill Cornell Medicine癌症生物学博士后机会: Faltas 实验室
|
|
博后招聘！ Faltas实验室欢迎您的加入。我们专注于融合前沿测序技术与基础肿瘤研究，深入探究基因不稳定性对肿瘤生物学的影响。本实验室位于纽约曼哈顿，实验室科研资金充足，团队合作紧密，氛围融洽。诚邀有志于肿瘤学研究的同仁加入，详情如下： Join the Faltas Lab: Postdoc Opportunities in Cancer Biology at Weill Cornell Medicine, NYC Are you a passionate and innovative researcher ready to make an impact in cancer biology? The Faltas Lab at Weill Cornell Medicine (https://faltaslab.weill.cornell.edu/) is seeking talented postdoctoral fellows and research associates to join our dynamic team. Embark on groundbreaking research projects supported by grants from the NIH, the Department of Defense, the Starr Cancer Consortium, the P-1000 Consortium, and the Albert Institute for Bladder Cancer Research. 🔬 Exciting Projects: 1) Dissecting the role of the APOBEC3 family of cytidine deaminases in genomic instability and bladder cancer evolution, metastasis. 2) The role of Extrachromosomal DNA in bladder cancer evolution. 3) Unraveling clonal evolutionary patterns in patient-derived bladder cancer organoids to uncover the molecular basis of targeted therapy resistance. 4) Investigating the impact of germline and somatic interactions on treatment response and bladder cancer evolution. 📚 Influential Publications: 1. Liu W, et al. The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer. Cancer Research. 2022 Dec 8:CAN-22-2912. doi: 10.1158/0008-5472.CAN-22-2912. Online ahead of print. PMID: 36480186 2. Vosoughi A, et al. Common germline-somatic variant interactions in advanced urothelial cancer Nature Communications. 2020 Dec 3;11(1):6195. doi: 10.1038/s41467-020-19971-8. 3. Robinson BD, et al. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nature Communications. 2019 Jul 5;10(1):2977. doi: 10.1038/s41467-019-10873-y. 4. Faltas BM, et al. Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nature Genetics. 2016 Dec;48(12):1490-1499. doi: 10.1038/ng.3692. 💡 Ideal Candidate: Earned or expected Ph.D. in cancer biology or related fields (between 2022-2024) Strong background in molecular biology and biochemistry techniques Track record of productivity (publications) from Ph.D. is a plus Excellent communication, organizational, and problem-solving skills Enthusiasm for pursuing postdoctoral training and a future independent academic career 💼 Why Join Us: We use a broad array of wet-lab and computational techniques, including single-cell sequencing, spatial proteomics, gene-editing, computational and mathematical modeling, and translational models, including patient-derived organoids. Our work was recently published in Nature, Nature Genetics, Nature Communications, and Cancer Research Thrive in a well-funded, stimulating environment dedicated to fostering future independent careers for postdoctoral trainees Collaborate with world-class bioinformatics teams at the Englander Institute for Precision Medicine Enjoy a vibrant and diverse lab culture focused on innovation, collaboration, and professional growth 📩 Apply Now: If you’re excited to join our team, please email the following documents to Dr. Bishoy M. Faltas at bmf9003@med.cornell.edu: CV Statement of research interests Copies of previous publications Names and contact information of three references Join us at Faltas Lab and contribute to cutting-edge research in cancer biology with the potential to make a positive impact on patients’ lives. |
回复此楼» 猜你喜欢
投稿Elsevier的杂志（返修），总是在选择OA和subscription界面被踢皮球
已经有8人回复
-
自荐读博
已经有7人回复
-
自然科学基金委宣布启动申请书“瘦身提质”行动
已经有4人回复
-
求个博导看看
已经有18人回复
-
青基代表作，AAAI之类的A会的special track在国内认可度高吗？还是归为workshop之流？
已经有3人回复
-
上海工程技术大学【激光智能制造】课题组招收硕士
已经有6人回复
-
上海工程技术大学张培磊教授团队招收博士生
已经有4人回复